title: Management of infections due to the varicella-zoster virus. 11th consensus conference on anti-infectious therapy of the French-speaking Society of Infectious Diseases (SPILF).
authors.affiliation: Hôpital de la Croix-Rousse, Service des Maladies infectieuses et tropicales, 93, grande rue de la Croix-Rousse, 69317 Lyon Cedex 04.
authors.forename: D
authors.initials: D
authors.lastname: Peyramond
authors.forename: C
authors.initials: C
authors.lastname: Chidiac
authors.forename: F
authors.initials: F
authors.lastname: Lucht
authors.forename: C
authors.initials: C
authors.lastname: Perronne
authors.forename: A G
authors.initials: AG
authors.lastname: Saimot
authors.forename: J C
authors.initials: JC
authors.lastname: Soussy
authors.forename: J P
authors.initials: JP
authors.lastname: Stahl
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D002644:Chickenpox / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D002648:Child; D005260:Female; D017408:Guidelines as Topic; D006562:Herpes Zoster / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D014645:Herpesvirus 3, Human; D006801:Humans; D016867:Immunocompromised Host; D007167:Immunotherapy; D015994:Incidence; D007223:Infant; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000628:therapy; D012307:Risk Factors; D012955:Societies, Medical
chemical_list: D000998:Antiviral Agents